Dr. Zongjin Li is a Professor at the Department of Pathophysiology and Director of the Laboratory of Molecular Imaging and Stem Cell Therapy at Nankai University School of Medicine, Tianjin, China. He received his PhD degree from Peking Union Medical College and completed his postdoctoral training at the MIPS (Molecular Imaging Program at Stanford) and the Department of Radiology at Stanford University (USA). Dr. Li has published more than 150 manuscripts with H-index of 49. Dr. Li conducts extensive research, focusing on stem cell therapy, extracellular vesicles (EVs), and molecular imaging. The goals of his research are to enhance our understanding of tissue regeneration and repair, accelerate the discovery of new therapeutics, and propose innovative strategies for sequential regulation and intervention in the treatment of tissue injuries, aging, and degenerative diseases. His work has appeared in peer-reviewed journals including Science Advance, Advance Science, Circulation, Journal of the American College of Cardiology, Journal of the American Society of Nephrology, Nature Methods, Biomaterials, and many more. Dr. Li is Vice Director of the Chinese Society of Biomedical Engineering, Council on Stem Cell Engineering, and International Fellow of the American Heart Association (FAHA).
